The over-the-counter medical application is intended for individuals aged 18 years and older who have not been previously diagnosed with sleep apnea.

Series 10 has the largest display of any Apple Watch to date, even bigger than the first Ultra. With up to 30 percent more ...

Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related ...

Positive airway pressure (PAP) utilization is associated with lower all-cause mortality and major adverse cardiovascular event (MACE) incidence in older adults with obstructive sleep apnea (OSA), ...

This shift towards patient-centered innovation is necessary. We're living in an aging society, where the needs of older ...

What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

The S&P 500 ended 0.3% lower on Wednesday, Sept. 18, 2024, as the Federal Reserve announced its first interest-rate cut since ...

In the release announcing its Watch Series 10’s availability, Apple refers to the device’s “refined” design. It’s an accurate ...

ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...

The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive ...

Vivos Therapeutics shares rose on Wednesday after the company said its oral medical device for pediatric sleep apnea and snoring received 510(k) clearance from the Food and Drug Administration. Shares ...